vs

Side-by-side financial comparison of BGSF, INC. (BGSF) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $22.0M, roughly 1.8× BGSF, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs -5.3%, a 29.9% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -9.4%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $1.7M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -5.3%).

BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

BGSF vs CDXS — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.8× larger
CDXS
$38.9M
$22.0M
BGSF
Growing faster (revenue YoY)
CDXS
CDXS
+90.7% gap
CDXS
81.3%
-9.4%
BGSF
Higher net margin
CDXS
CDXS
29.9% more per $
CDXS
24.7%
-5.3%
BGSF
More free cash flow
CDXS
CDXS
$17.9M more FCF
CDXS
$19.6M
$1.7M
BGSF
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-5.3%
BGSF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BGSF
BGSF
CDXS
CDXS
Revenue
$22.0M
$38.9M
Net Profit
$-1.2M
$9.6M
Gross Margin
35.0%
94.8%
Operating Margin
-17.6%
27.1%
Net Margin
-5.3%
24.7%
Revenue YoY
-9.4%
81.3%
Net Profit YoY
-18.2%
192.5%
EPS (diluted)
$-0.12
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BGSF
BGSF
CDXS
CDXS
Q4 25
$22.0M
$38.9M
Q3 25
$26.9M
$8.6M
Q2 25
$23.5M
$15.3M
Q1 25
$20.9M
$7.5M
Q4 24
$24.3M
$21.5M
Q3 24
$29.8M
$12.8M
Q2 24
$25.7M
$8.0M
Q1 24
$24.5M
$17.1M
Net Profit
BGSF
BGSF
CDXS
CDXS
Q4 25
$-1.2M
$9.6M
Q3 25
$-5.8M
$-19.6M
Q2 25
$-3.7M
$-13.3M
Q1 25
$-722.0K
$-20.7M
Q4 24
$-981.0K
$-10.4M
Q3 24
$-804.0K
$-20.6M
Q2 24
$-761.0K
$-22.8M
Q1 24
$-792.0K
$-11.5M
Gross Margin
BGSF
BGSF
CDXS
CDXS
Q4 25
35.0%
94.8%
Q3 25
35.9%
71.3%
Q2 25
35.8%
86.3%
Q1 25
36.2%
63.8%
Q4 24
35.9%
83.0%
Q3 24
35.9%
66.4%
Q2 24
37.3%
56.6%
Q1 24
38.1%
71.6%
Operating Margin
BGSF
BGSF
CDXS
CDXS
Q4 25
-17.6%
27.1%
Q3 25
-3.5%
-220.3%
Q2 25
-18.8%
-83.9%
Q1 25
1.6%
-271.6%
Q4 24
-15.7%
-34.2%
Q3 24
-3.4%
-129.0%
Q2 24
-5.7%
-284.9%
Q1 24
1.7%
-69.6%
Net Margin
BGSF
BGSF
CDXS
CDXS
Q4 25
-5.3%
24.7%
Q3 25
-21.6%
-228.1%
Q2 25
-15.9%
-86.6%
Q1 25
-3.5%
-274.3%
Q4 24
-4.0%
-48.4%
Q3 24
-2.7%
-160.8%
Q2 24
-3.0%
-285.2%
Q1 24
-3.2%
-67.4%
EPS (diluted)
BGSF
BGSF
CDXS
CDXS
Q4 25
$-0.12
$0.13
Q3 25
$-0.52
$-0.22
Q2 25
$-0.34
$-0.16
Q1 25
$-0.06
$-0.25
Q4 24
$-0.12
Q3 24
$-0.07
$-0.29
Q2 24
$-0.07
$-0.32
Q1 24
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BGSF
BGSF
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$48.1M
$50.5M
Total Assets
$57.8M
$147.8M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BGSF
BGSF
CDXS
CDXS
Q4 25
$78.2M
Q3 25
$41.2M
$58.7M
Q2 25
$2.8M
$66.3M
Q1 25
$2.0M
$59.8M
Q4 24
$32.0K
$73.5M
Q3 24
$262
$90.3M
Q2 24
$226
$73.2M
Q1 24
$50
$85.5M
Total Debt
BGSF
BGSF
CDXS
CDXS
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
BGSF
BGSF
CDXS
CDXS
Q4 25
$48.1M
$50.5M
Q3 25
$50.7M
$38.5M
Q2 25
$78.3M
$55.6M
Q1 25
$81.8M
$49.6M
Q4 24
$82.3M
$66.9M
Q3 24
$82.9M
$73.4M
Q2 24
$83.2M
$61.4M
Q1 24
$83.6M
$79.3M
Total Assets
BGSF
BGSF
CDXS
CDXS
Q4 25
$57.8M
$147.8M
Q3 25
$83.6M
$124.0M
Q2 25
$149.7M
$138.2M
Q1 25
$152.3M
$128.9M
Q4 24
$150.1M
$149.0M
Q3 24
$157.3K
$148.2M
Q2 24
$159.8K
$132.0M
Q1 24
$170.6K
$149.6M
Debt / Equity
BGSF
BGSF
CDXS
CDXS
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BGSF
BGSF
CDXS
CDXS
Operating Cash FlowLast quarter
$1.7M
$20.1M
Free Cash FlowOCF − Capex
$1.7M
$19.6M
FCF MarginFCF / Revenue
7.6%
50.3%
Capex IntensityCapex / Revenue
0.1%
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-16.0K
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BGSF
BGSF
CDXS
CDXS
Q4 25
$1.7M
$20.1M
Q3 25
$-4.8M
$-7.7M
Q2 25
$2.2M
$-18.0M
Q1 25
$1.1M
$-13.8M
Q4 24
$3.2M
$-16.5M
Q3 24
$6.5M
$-13.0M
Q2 24
$7.3M
$-12.2M
Q1 24
$7.4M
$-7.8M
Free Cash Flow
BGSF
BGSF
CDXS
CDXS
Q4 25
$1.7M
$19.6M
Q3 25
$-4.9M
$-7.9M
Q2 25
$2.1M
$-20.5M
Q1 25
$1.0M
$-15.1M
Q4 24
$2.5M
$-18.2M
Q3 24
$6.5M
$-14.0M
Q2 24
$7.3M
$-12.6M
Q1 24
$6.9M
$-8.9M
FCF Margin
BGSF
BGSF
CDXS
CDXS
Q4 25
7.6%
50.3%
Q3 25
-18.1%
-91.7%
Q2 25
9.1%
-133.6%
Q1 25
5.0%
-199.6%
Q4 24
10.2%
-85.0%
Q3 24
21.7%
-109.0%
Q2 24
28.5%
-157.5%
Q1 24
28.1%
-52.2%
Capex Intensity
BGSF
BGSF
CDXS
CDXS
Q4 25
0.1%
1.3%
Q3 25
0.4%
2.1%
Q2 25
0.0%
16.4%
Q1 25
0.1%
16.7%
Q4 24
3.0%
8.3%
Q3 24
0.0%
7.8%
Q2 24
0.0%
5.0%
Q1 24
2.0%
6.6%
Cash Conversion
BGSF
BGSF
CDXS
CDXS
Q4 25
2.09×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BGSF
BGSF

Contract Field Talent$21.4M97%
Other$595.0K3%

CDXS
CDXS

Segment breakdown not available.

Related Comparisons